(1R,3R,4Z,6R,7R)-3-ethyl-9-pent-2-en-4-ynyl-2,8-dioxabicyclo[5.2.1]dec-4-en-6-ol

Details

Top
Internal ID 685848f3-5367-4dcc-b35d-0739c176b242
Taxonomy Organoheterocyclic compounds > Tetrahydrofurans
IUPAC Name (1R,3R,4Z,6R,7R)-3-ethyl-9-pent-2-en-4-ynyl-2,8-dioxabicyclo[5.2.1]dec-4-en-6-ol
SMILES (Canonical) CCC1C=CC(C2CC(O1)C(O2)CC=CC#C)O
SMILES (Isomeric) CC[C@@H]1/C=C\[C@H]([C@H]2C[C@@H](O1)C(O2)CC=CC#C)O
InChI InChI=1S/C15H20O3/c1-3-5-6-7-13-15-10-14(18-13)12(16)9-8-11(4-2)17-15/h1,5-6,8-9,11-16H,4,7,10H2,2H3/b6-5?,9-8-/t11-,12-,13?,14-,15-/m1/s1
InChI Key GOJYGMSDJSXFHL-LSGGBAAFSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C15H20O3
Molecular Weight 248.32 g/mol
Exact Mass 248.14124450 g/mol
Topological Polar Surface Area (TPSA) 38.70 Ų
XlogP 2.00
Atomic LogP (AlogP) 1.82
H-Bond Acceptor 3
H-Bond Donor 1
Rotatable Bonds 3

Synonyms

Top
There are no found synonyms.

2D Structure

Top
2D Structure of (1R,3R,4Z,6R,7R)-3-ethyl-9-pent-2-en-4-ynyl-2,8-dioxabicyclo[5.2.1]dec-4-en-6-ol

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9948 99.48%
Caco-2 + 0.7151 71.51%
Blood Brain Barrier - 0.5250 52.50%
Human oral bioavailability - 0.6143 61.43%
Subcellular localzation Mitochondria 0.4354 43.54%
OATP2B1 inhibitior - 0.8584 85.84%
OATP1B1 inhibitior + 0.8561 85.61%
OATP1B3 inhibitior + 0.9498 94.98%
MATE1 inhibitior - 0.9800 98.00%
OCT2 inhibitior - 0.9250 92.50%
BSEP inhibitior - 0.8961 89.61%
P-glycoprotein inhibitior - 0.9199 91.99%
P-glycoprotein substrate - 0.8947 89.47%
CYP3A4 substrate - 0.5162 51.62%
CYP2C9 substrate - 0.6070 60.70%
CYP2D6 substrate - 0.7945 79.45%
CYP3A4 inhibition - 0.9272 92.72%
CYP2C9 inhibition - 0.8499 84.99%
CYP2C19 inhibition - 0.6939 69.39%
CYP2D6 inhibition - 0.9386 93.86%
CYP1A2 inhibition - 0.6281 62.81%
CYP2C8 inhibition - 0.8093 80.93%
CYP inhibitory promiscuity - 0.7382 73.82%
UGT catelyzed + 0.6000 60.00%
Carcinogenicity (binary) - 0.8700 87.00%
Carcinogenicity (trinary) Non-required 0.3947 39.47%
Eye corrosion - 0.9085 90.85%
Eye irritation - 0.9860 98.60%
Skin irritation - 0.6491 64.91%
Skin corrosion - 0.8724 87.24%
Ames mutagenesis - 0.6300 63.00%
Human Ether-a-go-go-Related Gene inhibition + 0.6458 64.58%
Micronuclear - 0.7400 74.00%
Hepatotoxicity + 0.5304 53.04%
skin sensitisation - 0.6352 63.52%
Respiratory toxicity + 0.5333 53.33%
Reproductive toxicity - 0.5222 52.22%
Mitochondrial toxicity + 0.5250 52.50%
Nephrotoxicity - 0.6709 67.09%
Acute Oral Toxicity (c) III 0.5567 55.67%
Estrogen receptor binding - 0.5087 50.87%
Androgen receptor binding - 0.7150 71.50%
Thyroid receptor binding - 0.5505 55.05%
Glucocorticoid receptor binding + 0.6295 62.95%
Aromatase binding - 0.6841 68.41%
PPAR gamma + 0.5849 58.49%
Honey bee toxicity - 0.8765 87.65%
Biodegradation - 0.7250 72.50%
Crustacea aquatic toxicity + 0.5700 57.00%
Fish aquatic toxicity - 0.4072 40.72%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 95.32% 96.09%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 94.72% 91.11%
CHEMBL226 P30542 Adenosine A1 receptor 92.30% 95.93%
CHEMBL253 P34972 Cannabinoid CB2 receptor 89.61% 97.25%
CHEMBL221 P23219 Cyclooxygenase-1 87.34% 90.17%
CHEMBL3137262 O60341 LSD1/CoREST complex 87.17% 97.09%
CHEMBL3401 O75469 Pregnane X receptor 85.88% 94.73%
CHEMBL1977 P11473 Vitamin D receptor 83.94% 99.43%
CHEMBL1994 P08235 Mineralocorticoid receptor 81.46% 100.00%

Plants that contains it

Top
Below are displayed all the plants proven (via scientific papers) to contain this compound!
To see more specific details click the taxa you are interested in.
There are no matching plants.

Cross-Links

Top
PubChem 163186294
LOTUS LTS0182307
wikiData Q105014086